Allspring Global Investments Holdings, LLC Arcturus Therapeutics Holdings Inc. Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	SELL	$24.35 - $44.39 $529,295 - $964,905	-21,737 Reduced 73.54%	7,820 $190,000
Q1 2024 Apr 18, 2024	SELL	$31.23 - $42.99 $2.66 Million - $3.67 Million	-85,253 Reduced 74.26%	29,557 $998,000
Q4 2023 Jan 25, 2024	BUY	$17.71 - $32.97 $1.41 Million - $2.62 Million	79,387 Added 224.11%	114,810 $3.62 Million
Q3 2023 Oct 27, 2023	BUY	$25.44 - $37.35 $901,161 - $1.32 Million	35,423 New	35,423 $905,000
Q2 2023 Jul 18, 2023	BUY	$23.94 - $32.36 $904,836 - $1.22 Million	37,796 Added 789.72%	42,582 $1.22 Million
Q1 2023 Apr 13, 2023	BUY	$14.72 - $23.97 $43,585 - $70,975	2,961 Added 162.25%	4,786 $114,000
Q4 2022 Jan 23, 2023	BUY	$14.14 - $23.06 $9,516 - $15,519	673 Added 58.42%	1,825 $0
Q3 2022 Oct 26, 2022	BUY	$13.05 - $22.13 $15,033 - $25,493	1,152 New	1,152 $17,000
Q2 2022 Jul 25, 2022	SELL	$12.26 - $31.17 $10,273 - $26,120	-838 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$17.64 - $39.57 $829 - $1,859	-47 Reduced 5.31%	838 $22,000
Q4 2021 Jan 28, 2022	BUY	$34.2 - $47.56 $30,267 - $42,090	885 New	885 $32,000

Others Institutions Holding ARCT

# of Institutions

179

Shares Held

25.6M

Call Options Held

195K

Put Options Held

133K

Federated Hermes, Inc. Pittsburgh, PA

4.69M
Shares

$72.7 Million
0.25% of portfolio
Black Rock Inc. New York, NY

2.65M
Shares

$41 Million
0.0% of portfolio
Nikko Asset Management Americas, Inc.

2.32M
Shares

$35.8 Million
0.62% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

2.28M
Shares

$35.2 Million
0.04% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

2.1M
Shares

$32.5 Million
0.46% of portfolio

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $411M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account